Northpointe Bancshares Inc
NYSE:NPB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Northpointe Bancshares Inc
NYSE:NPB
|
US |
|
PharmaCyte Biotech Inc
NASDAQ:PMCB
|
US |
|
Diverger Ltd
ASX:DVR
|
AU |
|
MIT Holdings Co Ltd
TSE:4016
|
JP |
|
E79 Resources Corp
F:4KL
|
CA |
|
Sparebanken More
OSE:MORG
|
NO |
|
A
|
Altair Resources Inc
F:90AA
|
CA |
|
Wolfden Resources Corp
F:WRC
|
CA |
|
A
|
Asia Hotel PCL
SET:ASIA
|
TH |
|
Oneapex Ltd
F:CWF
|
SG |
|
9
|
99 Acquisition Group Inc
NASDAQ:NNAG
|
US |
|
P
|
PSG Corporation PCL
SET:PSGC
|
TH |
Wall St Price Targets
NPB Price Targets Summary
Northpointe Bancshares Inc
According to Wall Street analysts, the average 1-year price target for NPB is 21.34 USD with a low forecast of 20.45 USD and a high forecast of 22.58 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPB's stock price target?
Price Target
21.34
USD
According to Wall Street analysts, the average 1-year price target for NPB is 21.34 USD with a low forecast of 20.45 USD and a high forecast of 22.58 USD.
What is the Revenue forecast for Northpointe Bancshares Inc?
Projected CAGR
9%
Over the last 2 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 2 years is 9%.
What is the Net Income forecast for Northpointe Bancshares Inc?
Projected CAGR
21%
Over the last 2 years, the compound annual growth rate for Net Income has been 72%. The projected CAGR for the next 2 years is 21%.
